Literature DB >> 28917986

Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Jasmim Leal1, Hugh D C Smyth1, Debadyuti Ghosh2.   

Abstract

Mucus is a selective barrier to particles and molecules, preventing penetration to the epithelial surface of mucosal tissues. Significant advances in transmucosal drug delivery have recently been made and have emphasized that an understanding of the basic structure, viscoelastic properties, and interactions of mucus is of great value in the design of efficient drug delivery systems. Mucins, the primary non-aqueous component of mucus, are polymers carrying a complex and heterogeneous structure with domains that undergo a variety of molecular interactions, such as hydrophilic/hydrophobic, hydrogen bonds and electrostatic interactions. These properties are directly relevant to the numerous mucin-associated diseases, as well as delivering drugs across the mucus barrier. Therefore, in this review we discuss regional differences in mucus composition, mucus physicochemical properties, such as pore size, viscoelasticity, pH, and ionic strength. These factors are also discussed with respect to changes in mucus properties as a function of disease state. Collectively, the review seeks to provide a state of the art roadmap for researchers who must contend with this critical barrier to drug delivery.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Mucins; Mucus barrier; Mucus filtering mechanisms; Viscoelasticity

Mesh:

Substances:

Year:  2017        PMID: 28917986      PMCID: PMC5744044          DOI: 10.1016/j.ijpharm.2017.09.018

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  290 in total

1.  Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.

Authors:  Henrik Nordman; Julia R Davies; Gert Lindell; Carme de Bolós; Francisco Real; Ingemar Carlstedt
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 2.  Nanomedicines for overcoming biological barriers.

Authors:  Maria José Alonso
Journal:  Biomed Pharmacother       Date:  2004-04       Impact factor: 6.529

3.  Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.

Authors:  Sara Kirkham; John K Sheehan; David Knight; Paul S Richardson; David J Thornton
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

5.  Histochemistry of mucus and other polysaccharides in tumors. I. Carcinoma of the bladder.

Authors:  P B Hukill; R A Vidone
Journal:  Lab Invest       Date:  1965-09       Impact factor: 5.662

6.  Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.

Authors:  Jung Soo Suk; Samuel K Lai; Nicholas J Boylan; Michelle R Dawson; Michael P Boyle; Justin Hanes
Journal:  Nanomedicine (Lond)       Date:  2011-02       Impact factor: 5.307

7.  Elemental composition of human airway surface fluid in healthy and diseased airways.

Authors:  L Joris; I Dab; P M Quinton
Journal:  Am Rev Respir Dis       Date:  1993-12

8.  Mucin gene expression in colonic tissues and cell lines.

Authors:  S Ogata; H Uehara; A Chen; S H Itzkowitz
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

Review 9.  Nanoparticle-based drug delivery to the vagina: a review.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  J Control Release       Date:  2014-05-14       Impact factor: 9.776

10.  Delphinidin Inhibits LPS-Induced MUC8 and MUC5B Expression Through Toll-like Receptor 4-Mediated ERK1/2 and p38 MAPK in Human Airway Epithelial Cells.

Authors:  Chang Hoon Bae; Bo Sung Jeon; Yoon Seok Choi; Si-Youn Song; Yong-Dae Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-08-01       Impact factor: 3.372

View more
  49 in total

Review 1.  Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.

Authors:  Zonghua Tian; Yaping Mai; Tingting Meng; Shijie Ma; Guojing Gou; Jianhong Yang
Journal:  AAPS PharmSciTech       Date:  2021-06-14       Impact factor: 3.246

2.  Molecular Characterization of Mucus Binding.

Authors:  Jacob Witten; Tahoura Samad; Katharina Ribbeck
Journal:  Biomacromolecules       Date:  2019-03-12       Impact factor: 6.988

Review 3.  Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities.

Authors:  Johan Karlsson; Kelly R Rhodes; Jordan J Green; Stephany Y Tzeng
Journal:  Expert Opin Drug Deliv       Date:  2020-07-31       Impact factor: 6.648

4.  A microrobotic system guided by photoacoustic computed tomography for targeted navigation in intestines in vivo.

Authors:  Zhiguang Wu; Lei Li; Yiran Yang; Peng Hu; Yang Li; So-Yoon Yang; Lihong V Wang; Wei Gao
Journal:  Sci Robot       Date:  2019-07-24

5.  Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery.

Authors:  Jasmim Leal; Xiujuan Peng; Xinquan Liu; Dhivya Arasappan; Dennis C Wylie; Sarah H Schwartz; Jason J Fullmer; Bennie C McWilliams; Hugh D C Smyth; Debadyuti Ghosh
Journal:  J Control Release       Date:  2020-03-31       Impact factor: 9.776

Review 6.  Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.

Authors:  Jian Fang; Hui Wang; Yuping Zhou; Hui Zhang; Huiting Zhou; Xiaohong Zhang
Journal:  Exp Mol Med       Date:  2021-05-17       Impact factor: 8.718

Review 7.  Human ocular mucins: The endowed guardians of sight.

Authors:  Pablo Argüeso
Journal:  Adv Drug Deliv Rev       Date:  2021-12-04       Impact factor: 15.470

8.  Spatial configuration of charge and hydrophobicity tune particle transport through mucus.

Authors:  Tahoura Samad; Jacob Witten; Alan J Grodzinsky; Katharina Ribbeck
Journal:  Biophys J       Date:  2021-12-21       Impact factor: 4.033

9.  Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.

Authors:  Jonathan Wang; Deborah Chin; Christopher Poon; Valeria Mancino; Jessica Pham; Hui Li; Pei-Yin Ho; Kenneth R Hallows; Eun Ji Chung
Journal:  J Control Release       Date:  2020-10-28       Impact factor: 9.776

Review 10.  Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

Authors:  Michael C McKelvey; Ryan Brown; Sinéad Ryan; Marcus A Mall; Sinéad Weldon; Clifford C Taggart
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.